Gene RADAR: ctRNA and ctDNA single Molecule Digital Reading

a patented ctRNA + ctDNA combination blood test​

Liquid biopsies, or blood tests to detect molecular biomarkers of cancer cells, have traditionally tested only at patients' circulating DNA level. However, many clinically meaningful cancer variants exist at both the DNA and RNA level, and some occur only at the RNA level such as RNA splicing. By examining cfDNA and cfRNA released by cancer cells into blood vessels simultaneously, Gene RADAR boosts detection sensitivity and specificity for genes of interest in circulation.